| Morton’s Inhaler | |
|---|---|
| |
|
Origin |
William T. G. Morton |
|
Type |
Ether Inhaler |
|
Effects |
Enhances the effectiveness of any medical compound |
|
Downsides |
Ether vapor sickness, memory loss |
|
Activation |
Inhalation and medicine consumption |
|
Collected by |
Warehouse 13 |
|
Section |
|
|
Date of Collection |
February 26, 1922 |
| [Source] | |
Origin[]
William Thomas Green Morton (August 9, 1819 – July 15, 1868) was an American dentist and physician who first publicly demonstrated the use of inhaled ether as a surgical anesthetic in 1846. Many were skeptical since other anesthetic compounds of the time either didn’t alleviate the pain, caused illness or were fatal in overdoses.
After a first successful tooth removal, Morton performed his next operation for other dentist’s viewing at the Massachusetts General Hospital. A previous attempt by Morton’s colleague Horace Wells with nitrous oxide at the MGH failed to put the subject at rest. Ether however was more effective, with the patient feeling nothing after awakening. The first dean of Harvard Medical School would later remove a neck tumor from another patient and cement ether as an effective, non-toxic anesthetic. Employees and colleagues would afterwards claim Morton’s research as unscientific to seize the rights of any patents he filed.
Effects[]
Makes any medicine, over the counter or home remedy, more effective than normal. Simply take the desired medicine before or after inhaling water vapor from the glass tube. It boosts whatever healing qualities the compound targets to act faster with greater spread. Acts as a second or even third dose without the equivalent amount of side effects.
However, it does seem to recreate the negative effects of ether addiction. One may knock out unconscious after multiple uses, start coughing violently from the strong odor of the vapors and even become high unexpectedly. Memory loss similar to narcoleptic fits or epilepsy seizures is also common.
Felix’s Notes[]
“Alters the therapeutic index of a drug, increasing the rate of successful treatment versus toxic over-exposure. It appears to make one round of medicine have greater efficiency, regardless of whatever biological process it targets. Noted to work best on medicines that require inhalation or oral intake, and less well on intravenous solutions like blood plasma or topical treatments. Perhaps the less directly it targets the respiratory or digestive tracts, both connected to the mouth and sinuses, the less improved it becomes. Maybe it can alter how much of each chemical compound my body needs to produce to function? All of this was tested with Vanessa under her medical supervision, so more testing may be in the pipeline."